Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

Centro di Riferimento Oncologico - Aviano · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
antineoplastic-agentsbiomarkerbreastbreast-neoplasmsepigeneticsliquid-biopsyneoplasms
hormone receptor positive breast carcinoma, breast neoplasms, neoplasms, breast, breast diseases, antineoplastic agents, aromatase inhibitors, esr1 gene mutation, epigenetics, liquid biopsy, ctdna, biomarker, hr-positive her2-negative
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 904483
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.